amc pharma limited
amc pharma limited Company Information
Group Structure
View All
Industry
Manufacture of other food products n.e.c.
+3Registered Address
14 chichester way, london, E14 3EG
Website
http://forexzoneltd.comamc pharma limited Estimated Valuation
Pomanda estimates the enterprise value of AMC PHARMA LIMITED at £362.3k based on a Turnover of £837.4k and 0.43x industry multiple (adjusted for size and gross margin).
amc pharma limited Estimated Valuation
Pomanda estimates the enterprise value of AMC PHARMA LIMITED at £334.8k based on an EBITDA of £86.8k and a 3.86x industry multiple (adjusted for size and gross margin).
amc pharma limited Estimated Valuation
Pomanda estimates the enterprise value of AMC PHARMA LIMITED at £0 based on Net Assets of £-53.7k and 2.22x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Amc Pharma Limited Overview
Amc Pharma Limited is a live company located in london, E14 3EG with a Companies House number of 07675886. It operates in the manufacture of other food products n.e.c. sector, SIC Code 10890. Founded in June 2011, it's largest shareholder is amc pharma gmbh with a 100% stake. Amc Pharma Limited is a established, small sized company, Pomanda has estimated its turnover at £837.4k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Amc Pharma Limited Health Check
Pomanda's financial health check has awarded Amc Pharma Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs
2 Strong
5 Regular
4 Weak
Size
annual sales of £837.4k, make it smaller than the average company (£11.4m)
- Amc Pharma Limited
£11.4m - Industry AVG
Growth
3 year (CAGR) sales growth of 6%, show it is growing at a similar rate (6.3%)
- Amc Pharma Limited
6.3% - Industry AVG
Production
with a gross margin of 31.6%, this company has a comparable cost of product (31.6%)
- Amc Pharma Limited
31.6% - Industry AVG
Profitability
an operating margin of 10.4% make it more profitable than the average company (4.1%)
- Amc Pharma Limited
4.1% - Industry AVG
Employees
with 4 employees, this is below the industry average (46)
- Amc Pharma Limited
46 - Industry AVG
Pay Structure
on an average salary of £42.3k, the company has an equivalent pay structure (£42.3k)
- Amc Pharma Limited
£42.3k - Industry AVG
Efficiency
resulting in sales per employee of £209.3k, this is equally as efficient (£242.3k)
- Amc Pharma Limited
£242.3k - Industry AVG
Debtor Days
it gets paid by customers after 36 days, this is near the average (40 days)
- Amc Pharma Limited
40 days - Industry AVG
Creditor Days
its suppliers are paid after 86 days, this is slower than average (35 days)
- Amc Pharma Limited
35 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Amc Pharma Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (15 weeks)
1 weeks - Amc Pharma Limited
15 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 126%, this is a higher level of debt than the average (59.6%)
126% - Amc Pharma Limited
59.6% - Industry AVG
AMC PHARMA LIMITED financials
Amc Pharma Limited's latest turnover from December 2023 is estimated at £837.4 thousand and the company has net assets of -£53.7 thousand. According to their latest financial statements, we estimate that Amc Pharma Limited has 4 employees and maintains cash reserves of £3.7 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||
| Other Income Or Grants | |||||||||||||
| Cost Of Sales | |||||||||||||
| Gross Profit | |||||||||||||
| Admin Expenses | |||||||||||||
| Operating Profit | |||||||||||||
| Interest Payable | |||||||||||||
| Interest Receivable | |||||||||||||
| Pre-Tax Profit | |||||||||||||
| Tax | |||||||||||||
| Profit After Tax | |||||||||||||
| Dividends Paid | |||||||||||||
| Retained Profit | |||||||||||||
| Employee Costs | |||||||||||||
| Number Of Employees | 3 | 10 | 21 | 21 | |||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | |||||||||||||
| Intangible Assets | 6,907 | 6,907 | 6,907 | 6,907 | 6,907 | ||||||||
| Investments & Other | |||||||||||||
| Debtors (Due After 1 year) | 55,411 | 15,652 | 15,652 | ||||||||||
| Total Fixed Assets | 62,318 | 22,559 | 22,559 | 6,907 | 6,907 | ||||||||
| Stock & work in progress | 48,155 | 53,527 | 55,418 | 98,802 | 131,282 | 120,734 | 28,987 | 1,640 | |||||
| Trade Debtors | 83,713 | 69,326 | 14,826 | 49,275 | 26,531 | 50,978 | 201,964 | 170,438 | 32,944 | 151,364 | 104,316 | 93,567 | |
| Group Debtors | 20,384 | 20,204 | 9,259 | 14,484 | 2,646 | 71,860 | 73,052 | ||||||
| Misc Debtors | 56,815 | 34,211 | 32,376 | 16,737 | 16,737 | 13,752 | 20,346 | 9,925 | 9,350 | ||||
| Cash | 3,719 | 54,240 | 7,182 | 79,724 | 114,995 | 107,523 | 54,361 | 73,890 | 53,808 | 14,908 | 14,402 | 11,230 | |
| misc current assets | |||||||||||||
| total current assets | 144,247 | 178,161 | 74,588 | 203,150 | 226,274 | 230,317 | 375,473 | 457,395 | 289,888 | 195,259 | 120,358 | 104,797 | |
| total assets | 206,565 | 200,720 | 97,147 | 210,057 | 233,181 | 230,317 | 375,473 | 457,395 | 289,888 | 195,259 | 120,358 | 104,797 | |
| Bank overdraft | |||||||||||||
| Bank loan | |||||||||||||
| Trade Creditors | 135,143 | 213,066 | 65,078 | 222,739 | 283,210 | 136,435 | 196,295 | 332,529 | 72,686 | 162,895 | 99,241 | 171,154 | |
| Group/Directors Accounts | 21,999 | 23,561 | 23,561 | 111,007 | 88,991 | 85,437 | 133,427 | 26,662 | |||||
| other short term finances | |||||||||||||
| hp & lease commitments | |||||||||||||
| other current liabilities | 869 | 2,887 | 9,351 | 19,575 | 44,486 | 185,564 | |||||||
| total current liabilities | 157,142 | 236,627 | 88,639 | 334,615 | 375,088 | 231,223 | 349,297 | 403,677 | 258,250 | 162,895 | 99,241 | 171,154 | |
| loans | 23,561 | ||||||||||||
| hp & lease commitments | |||||||||||||
| Accruals and Deferred Income | |||||||||||||
| other liabilities | 79,523 | 82,971 | 79,347 | 119,522 | 118,452 | ||||||||
| provisions | |||||||||||||
| total long term liabilities | 103,084 | 82,971 | 79,347 | 119,522 | 118,452 | ||||||||
| total liabilities | 260,226 | 319,598 | 167,986 | 454,137 | 493,540 | 231,223 | 349,297 | 403,677 | 258,250 | 162,895 | 99,241 | 171,154 | |
| net assets | -53,661 | -118,878 | -70,839 | -244,080 | -260,359 | -906 | 26,176 | 53,718 | 31,638 | 32,364 | 21,117 | -66,357 | |
| total shareholders funds | -53,661 | -118,878 | -70,839 | -244,080 | -260,359 | -906 | 26,176 | 53,718 | 31,638 | 32,364 | 21,117 | -66,357 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||
| Operating Profit | |||||||||||||
| Depreciation | |||||||||||||
| Amortisation | |||||||||||||
| Tax | |||||||||||||
| Stock | -48,155 | -5,372 | -1,891 | -43,384 | -32,480 | 10,548 | 91,747 | 27,347 | 1,640 | ||||
| Debtors | 56,366 | 56,515 | 7,787 | 17,519 | -9,624 | -154,934 | -29,913 | 136,877 | -36,018 | 47,048 | 10,749 | 93,567 | |
| Creditors | -77,923 | 147,988 | -157,661 | -60,471 | 146,775 | -59,860 | -136,234 | 259,843 | -90,209 | 63,654 | -71,913 | 171,154 | |
| Accruals and Deferred Income | -869 | -2,018 | -6,464 | -10,224 | -24,911 | -141,078 | 185,564 | ||||||
| Deferred Taxes & Provisions | |||||||||||||
| Cash flow from operations | |||||||||||||
| Investing Activities | |||||||||||||
| capital expenditure | |||||||||||||
| Change in Investments | |||||||||||||
| cash flow from investments | |||||||||||||
| Financing Activities | |||||||||||||
| Bank loans | |||||||||||||
| Group/Directors Accounts | -1,562 | -87,446 | 22,016 | 3,554 | -47,990 | 106,765 | 26,662 | ||||||
| Other Short Term Loans | |||||||||||||
| Long term loans | 23,561 | ||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||
| other long term liabilities | -3,448 | 3,624 | -40,175 | 1,070 | 118,452 | ||||||||
| share issue | |||||||||||||
| interest | |||||||||||||
| cash flow from financing | |||||||||||||
| cash and cash equivalents | |||||||||||||
| cash | -50,521 | 47,058 | -72,542 | -35,271 | 7,472 | 53,162 | -19,529 | 20,082 | 38,900 | 506 | 3,172 | 11,230 | |
| overdraft | |||||||||||||
| change in cash | -50,521 | 47,058 | -72,542 | -35,271 | 7,472 | 53,162 | -19,529 | 20,082 | 38,900 | 506 | 3,172 | 11,230 |
amc pharma limited Credit Report and Business Information
Amc Pharma Limited Competitor Analysis
Perform a competitor analysis for amc pharma limited by selecting its closest rivals, whether from the MANUFACTURING sector, other small companies, companies in E14 area or any other competitors across 12 key performance metrics.
amc pharma limited Ownership
AMC PHARMA LIMITED group structure
Amc Pharma Limited has no subsidiary companies.
Ultimate parent company
AMC PHARMA GMBH
#0101816
1 parent
AMC PHARMA LIMITED
07675886
amc pharma limited directors
Amc Pharma Limited currently has 1 director, Mr Miroslaw Godek serving since Apr 2016.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Miroslaw Godek | England | 67 years | Apr 2016 | - | Director |
P&L
December 2023turnover
837.4k
-10%
operating profit
86.8k
0%
gross margin
31.7%
-0.78%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-53.7k
-0.55%
total assets
206.6k
+0.03%
cash
3.7k
-0.93%
net assets
Total assets minus all liabilities
Similar Companies
amc pharma limited company details
company number
07675886
Type
Private limited with Share Capital
industry
10890 - Manufacture of other food products n.e.c.
82990 - Other business support service activities n.e.c.
47910 - Retail sale via mail order houses or via Internet
incorporation date
June 2011
age
14
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
-
address
14 chichester way, london, E14 3EG
Bank
-
Legal Advisor
-
amc pharma limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to amc pharma limited.
amc pharma limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AMC PHARMA LIMITED. This can take several minutes, an email will notify you when this has completed.
amc pharma limited Companies House Filings - See Documents
| date | description | view/download |
|---|
